Publikationen, an denen er mitarbeitet MIRIAN ALKORTA GURRUTXAGA (10)

2023

  1. Migrantes subsaharianos, piuria estéril y esquistosomiasis: (Pag.-e 101952)

    Semergen: revista española de medicina de familia, Núm. 5, pp. 11-11

  2. Validation of an expanded, in-house library and an optimized preparation method for the identification of fungal isolates using MALDI-TOF mass spectrometry

    Medical mycology, Vol. 61, Núm. 4

2020

  1. Erratum: Zoonotic approach to Shiga toxin-producing Escherichia coli: Integrated analysis of virulence and antimicrobial resistance in ruminants and humans (Journal of Physical Chemistry DOI: 10.1017/S0950268819000566)

    Epidemiology and Infection

2019

  1. Zoonotic approach to shiga toxin-producing Escherichia coli: Integrated analysis of virulence and antimicrobial resistance in ruminants and humans

    Epidemiology and Infection, Vol. 147, pp. 1-9

2017

  1. GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination

    Oncotarget, Vol. 8, Núm. 33, pp. 53916-53934

  2. Thirty years of human infections caused by Yersinia enterocolitica in northern Spain: 1985-2014

    Epidemiology and Infection, Vol. 145, Núm. 11, pp. 2197-2203

2016

  1. Biomarker tools to design clinical vaccines determined from a study of annual listeriosis incidence in northern Spain

    Frontiers in Immunology, Vol. 7, Núm. NOV

2014

  1. Two outbreaks of listeria monocytogenes infection, Northern Spain

    Emerging Infectious Diseases, Vol. 20, Núm. 12, pp. 2155-2157

2005

  1. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point

    International Journal of Antimicrobial Agents, Vol. 25, Núm. 2, pp. 163-167

2001

  1. Prediction of In-vivo efficacy by In-vitro early bactericidal activity with oral β-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin

    Journal of Chemotherapy, Vol. 13, Núm. 2, pp. 118-125